|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||
| Deferred Offering Cost | |||||||||
| Cash | |||||||||
| Other receivables | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Long-term prepaid expenses | |||||||||
| Investments held in Trust Account | |||||||||
| Total Assets | |||||||||
| Accrued offering costs and expenses | |||||||||
| Current liabilities: | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Promissory note, at fair value | |||||||||
| Taxes payable | |||||||||
| Note payable - related party | |||||||||
| Total current liabilities | |||||||||
| Warrant liability | |||||||||
| Total Liabilities | |||||||||
| Common stock subject to possible redemption; 27,600,000 shares at redemption value of $10.14 and $10.00 at September 30, 2022 and December 31, 2021, respectively | |||||||||
| Stockholders’ Deficit: | |||||||||
| Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 752,000 shares issued and outstanding, excluding 27,600,000 shares subject to possible redemption | |||||||||
| Class A common stock | |||||||||
| Class B Common Stock | |||||||||
| Total class A common stock, $0.0001 par value; 200,000,000 shares authorized; 752,000 shares issued and outstanding, excluding 27,600,000 shares subject to possible redemption | |||||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Stockholders’ Deficit | |||||||||
| Class A common stock | |||||||||
| Class B Common Stock | |||||||||
| Total Stockholders’ Deficit | |||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
